dc.contributor.author |
Охунов А.О. Бобокулова Ш.А. |
|
dc.date.accessioned |
2023-02-15T03:34:58Z |
|
dc.date.available |
2023-02-15T03:34:58Z |
|
dc.date.issued |
2023-02 |
|
dc.identifier.issn |
2749-3644 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/6311 |
|
dc.description.abstract |
Background. The COVID-19 pandemic has shown how much coronavirus
infection can be contagious. Even now, doctors are facing the consequences of
this viral disease. A high lesion of the pulmonary system causes an increase in
the proportion of consequences of respiratory disease. One of the difficult
aspects in this direction is lung abscesses.
Material.
An analysis of different approaches in the treatment of lung abscesses of
patients who have had COVID-19 was carried out. All patients, depending on
the severity of the course of purulent lung disease and treatment methods,
were divided into 3 groups.
Results. The main positive therapeutic effect in the treatment of lung
abscesses in patients with COVID-19 should be reduced to the effects of
endothelialitis. For this, long-term intraarterial catheter therapy and local
ultrasound cavitation of the lung destruction cavity were used. Significant
positive results were obtained in all major groups where a differentiated
treatment approach was used.
Conclusion. The use of the therapeutic and diagnostic algorithm developed
by us leads to an improvement in the clinical, radiological and ultrasound
picture of the disease, allows us to reduce the duration of inpatient treatment
by 7 days, as well as improve clinical outcomes, including, to increase the
proportion of patients with complete recovery by 23% and reduce the
frequency of the transition of an abscess to a chronic form by half. |
en_US |
dc.language.iso |
en |
en_US |
dc.subject |
acute lung abscesses, COVID-19, endothelialitis, long-term intraarterial catheter therapy, ultrasound cavitation. |
en_US |
dc.title |
NEW APPROACHES TO TREATING LUNG ABSCESSES AS COVID 19 SEQUELS. |
en_US |
dc.type |
Article |
en_US |